Insights

Fast time to market Celsis provides 80% faster release screening for a wide range of industries, enabling potential customers to reduce hold times, decrease inventory, and accelerate product launches.

Global validation With over 800 installations in 65 countries and acceptance as a release method on new drug applications since 1997, there is a proven track record that can be leveraged to reassure potential pharmaceutical and consumer product clients.

Cost and capital relief The rapid testing and faster release capability translates into working capital savings by freeing up products to market sooner, which appeals to manufacturers seeking efficiency and procurement teams focused on cost containment.

Industry leadership Celsis positions itself as the leading innovator in rapid detection methods for industrial applications, presenting a compelling case to enterprises in Home, Beauty, Dairy, Beverage, Food, and Pharmaceutical sectors.

Partnership approach The end-to-end support from assessment through validation and implementation offers a consultative sales angle, enabling cross-sell opportunities across multiple product lines and regions.

Similar companies to Celsis In Vitro Technologies

Celsis In Vitro Technologies's Email Address Formats

Celsis In Vitro Technologies uses at least 1 email format:
Celsis In Vitro Technologies Email FormatsExamplePercentage
FLast@celsis.comJDoe@celsis.com
100%

Frequently Asked Questions

What is Celsis In Vitro Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Celsis In Vitro Technologies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Celsis In Vitro Technologies's official website and social media links?

Minus sign iconPlus sign icon
Celsis In Vitro Technologies's official website is celsis.com and has social profiles on LinkedIn.

How much revenue does Celsis In Vitro Technologies generate?

Minus sign iconPlus sign icon
As of July 2026, Celsis In Vitro Technologies's annual revenue is estimated to be $10M - $25M.

What is Celsis In Vitro Technologies's SIC code and NAICS code?

Minus sign iconPlus sign icon
Celsis In Vitro Technologies's SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Celsis In Vitro Technologies have currently?

Minus sign iconPlus sign icon
As of July 2026, Celsis In Vitro Technologies has approximately 51 employees across 2 continents, including North America and Europe. Key team members include Account Manager: B. C. Explore Celsis In Vitro Technologies's employee directory with LeadIQ.

What industry does Celsis In Vitro Technologies belong to?

Minus sign iconPlus sign icon
Celsis In Vitro Technologies operates in the Biotechnology industry.

What is Celsis In Vitro Technologies's email format?

Minus sign iconPlus sign icon
Celsis In Vitro Technologies's email format typically follows the pattern of FLast@celsis.com. Find more Celsis In Vitro Technologies email formats with LeadIQ.
Celsis In Vitro Technologies logo

Celsis In Vitro Technologies

BiotechnologyIllinois, United States51-200 Employees

Celsis In Vitro Technologies is a mid-sized biotechnology firm based in Chicago, Illinois. It specializes in rapid detection methods for industrial use, helping customers bring products to market faster while reducing hold times, inventory needs, and overall costs without compromising quality or consumer safety. Its rapid product-release screening can yield definitive results in 18 to 24 hours, a considerable speed-up over traditional microbial testing, and serves a range of sectors including Home, Beauty, Chemical, Dairy (UHT/ESL), Beverage, Food, and Pharmaceutical. 

Globally, the company supports its customers with more than 800 installations across 65 countries, highlighting its widespread reach. The systems and assays it provides aim to match the accuracy of conventional testing but on a faster timeline, and the organization concentrates exclusively on rapid detection methods for industrial applications. Since 1997, its release method has been accepted for new drug applications and it has been validated across hundreds of product types, indicating a long track record of regulatory alignment and practical use.

Section iconCompany Overview

Phone number
Website
celsis.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    Celsis In Vitro Technologies's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.